240 likes | 516 Views
Top Down Therapy vs Step Up Therapy in Pediatric Patients with new onset Crohn’s Disease. Presenters Dr Ali Minhas M.B.B.S Dr Orooj Khan M.B.B.S Mentor Dr Maya D Srivastava M.D. Background.
E N D
Top Down Therapy vs Step Up Therapy in Pediatric Patients with new onset Crohn’s Disease Presenters Dr Ali Minhas M.B.B.S Dr Orooj Khan M.B.B.S Mentor Dr Maya D Srivastava M.D
Background • Top-down (TD) therapy with tumor necrosis factor inhibitors early in disease course of adult Crohn's disease (CD) has been shown to result in decreased steroid dependence, hospitalizations, complications, and disease activity compared to conventional step-up (SU) therapy
Background • Anti-TNF is effective in pediatric patients with CD failing conventional step up therapy • Data regarding Top Down therapy in pediatric patients is limited
Introduction Aim • To compare top down therapy with step up therapy in relation to achieving early remission and prevention of known disease complications in pediatric patients with new onset Crohn’s Disease
Introduction Top Down Therapy • Inclusion of biologic agents as initiation therapy to alter the course of Crohn’s disease Step Up Therapy • Use of least efficacious to most potent agents in a step wise fashion to alter the course of Crohn’s Disease
Crohn’s Disease Management Pyramids Step Up Therapy Top Down Therapy
Study Design • Retrospective chart review of all pediatric patients (age under 18) with CD in an outpatient solo practice • Charts reviewed dated from 2007-2009 • 89 charts identified by diagnostic billing codes for CD (555.0, 555.1, 555.2) • 21 patients satisfied the inclusion criteria and all were included in the study
Study Design • Crohn’s Disease Activity Index (CDAI) used to calculate the severity of CD • Data analysis conducted by using unpaired t test and Fischer’s exact test • IRB exempt
Crohn’s Disease Activity Index Scoring System • Mild Disease 150-199 • Moderate Disease 200-449 • Severe Disease >450 • Remission <150
Conclusions • TD strategy is more effective in rapidly gaining and maintaining control in the first year of diagnosis in pediatric patients with new onset Crohn’s disease • TD therapy associated with decreased complications of disease, relapses and steroid dependence in the first year of diagnosis
Conclusions • Almost all patients on step up therapy relapsed in the first year and required anti-TNF salvage
Study Evaluation • Small sample size • Retrospective study • Insurance Approval Barriers